FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 1945588 · Received January 4, 2011

Report

Report Number
2124215-2010-19913
Event Type
Injury
Date Received
January 4, 2011
Date of Event
September 9, 2010
Report Date
October 11, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

NO ADVERSE PATIENT EFFECTS WERE REPORTED. THE SHOCKING PORTION OF THE CHRONIC DEFIBRILLATION LEAD REMAINS IN SERVICE WITH THE NEW DEVICE.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THE RATE/SENSE PORTION OF THIS CHRONIC DEFIBRILLATION LEAD COULD NOT BE FULLY INSERTED INTO THE NEW DEVICE DURING THE CHANGE OUT PROCEDURE. THE PHYSICIAN SUCCESSFULLY TESTED THE RATE/SENSE PORTION OF A NEW BOSTON SCIENTIFIC DEFIBRILLATION LEAD FOR INSERTION INTO THE NEW DEVICE PRIOR TO IMPLANT. HOWEVER, THE NEW DEFIBRILLATION LEAD WAS NOT IMPLANTED. THE HIGH VOLTAGE TERMINAL PINS FROM THE CHRONIC DEFIBRILLATION LEAD WERE INSERTED INTO THE NEW DEVICE WITHOUT COMPLICATION, SO THE PHYSICIAN SURGICALLY ABANDONED THE RATE/SENSE PORTION OF THE CHRONIC DEFIBRILLATION LEAD AND IMPLANTED A NEW PACING LEAD IN THE RIGHT VENTRICLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0158

Patients

Seq Age Sex Outcome Treatment
1 77 YR Required Intervention 0185| 4136| 0158| E110| T165| 4086